• Mount Sinai Hospital was on the frontlines of treating COVID-19 in the early phase of the pandemic.

• Candida auris, a multidrug-resistant fungus, was identified first in the United States in 2016; since then, hospitals in New York have been the hotspots.

• During the study period, they identified 64 cases, 34 by surveillance and 30 by clinical culture, with the incidence rising from 2.6 per 10,000 admissions in 2019 to 7.8 in 2022.

• The total incidence was 4.9 cases per 10,000 from 2019 to 2022.

• The authors say the increasing incidence of C. auris could be due to multiple factors associated with the pandemic.

• The study results highlight the potential impact of the COVID-19 pandemic on the spread of Multiple Drug Resistant Organisms (MDROs) and how targeted surveillance can serve as a valuable tool to combat the increasing spread of C. auris.

Click here to read more